| Allogeneic CAR cell therapy—more than a pipe dream KJ Caldwell, S Gottschalk, AC Talleur Frontiers in immunology 11, 618427, 2021 | 92 | 2021 |
| Hemophagocytic lymphohistiocytosis‐like toxicity (carHLH) after CD19‐specific CAR T‐cell therapy MR Hines, C Keenan, G Maron Alfaro, C Cheng, Y Zhou, A Sharma, ... British journal of haematology 194 (4), 701-707, 2021 | 71 | 2021 |
| CD19-CAR T cells undergo exhaustion DNA methylation programming in patients with acute lymphoblastic leukemia CC Zebley, C Brown, T Mi, Y Fan, S Alli, S Boi, G Galletti, E Lugli, ... Cell reports 37 (9), 2021 | 53 | 2021 |
| Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome MR Hines, TE Knight, KO McNerney, MB Leick, T Jain, S Ahmed, ... Transplantation and Cellular Therapy 29 (7), 438. e1-438. e16, 2023 | 52 | 2023 |
| Consolidation Therapy for Newly Diagnosed Pediatric Patients with High-Risk Neuroblastoma Using Busulfan/Melphalan, Autologous Hematopoietic Cell Transplantation, Anti-GD2 … AC Talleur, BM Triplett, S Federico, E Mamcarz, W Janssen, J Wu, ... Biology of Blood and Marrow Transplantation 23 (11), 1910-1917, 2017 | 45 | 2017 |
| Improved survival rate in T-cell depleted haploidentical hematopoietic cell transplantation over the last 15 years at a single institution E Mamcarz, R Madden, A Qudeimat, A Srinivasan, A Talleur, A Sharma, ... Bone marrow transplantation 55 (5), 929-938, 2020 | 36 | 2020 |
| Limited margin radiation therapy for children and young adults with Ewing sarcoma achieves high rates of local tumor control AC Talleur, F Navid, SL Spunt, MB McCarville, J Wu, S Mao, AM Davidoff, ... International Journal of Radiation Oncology* Biology* Physics 96 (1), 119-126, 2016 | 35 | 2016 |
| Treatment intensity and symptom burden in hospitalized adolescent and young adult hematopoietic cell transplant recipients at the end of life JM Snaman, AC Talleur, J Lu, DR Levine, EC Kaye, A Sykes, Z Lu, ... Bone marrow transplantation 53 (1), 84-90, 2018 | 31 | 2018 |
| Common trajectories of highly effective CD19-specific CAR T cells identified by endogenous T-cell receptor lineages TL Wilson, H Kim, CH Chou, D Langfitt, RC Mettelman, AA Minervina, ... Cancer discovery 12 (9), 2098-2119, 2022 | 28 | 2022 |
| Impact of high disease burden on survival in pediatric patients with B-ALL treated with tisagenlecleucel JW Ravich, S Huang, Y Zhou, P Brown, CH Pui, H Inaba, C Cheng, ... Transplantation and cellular therapy 28 (2), 73. e1-73. e9, 2022 | 23 | 2022 |
| Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL AC Talleur, A Qudeimat, JY Métais, D Langfitt, E Mamcarz, JC Crawford, ... Blood Advances 6 (21), 5737-5749, 2022 | 22 | 2022 |
| Anakinra utilization in refractory pediatric CAR T-cell associated toxicities C Diorio, A Vatsayan, AC Talleur, C Annesley, JJ Jaroscak, H Shalabi, ... Blood advances 6 (11), 3398-3403, 2022 | 21 | 2022 |
| Diagnostic approach to the evaluation of myeloid malignancies following CAR T-cell therapy in B-cell acute lymphoblastic leukemia G Mo, HW Wang, AC Talleur, SA Shahani, B Yates, H Shalabi, ... Journal for immunotherapy of cancer 8 (2), 2020 | 20 | 2020 |
| Longitudinal NK cell kinetics and cytotoxicity in children with neuroblastoma enrolled in a clinical phase II trial R Nguyen, N Sahr, A Sykes, MB McCarville, SM Federico, A Sooter, ... Journal for immunotherapy of cancer 8 (1), 2020 | 15 | 2020 |
| Infectious complications in pediatric, adolescent and young adult patients undergoing CD19-CAR T cell therapy GM Maron, DR Hijano, R Epperly, Y Su, L Tang, RT Hayden, S Naik, ... Frontiers in oncology 12, 845540, 2022 | 14 | 2022 |
| Thoughts from the threshold: patient and family hopes, fears, values, and goals at the onset of pediatric hematopoietic cell transplantation DR Levine, K Van Noy, AC Talleur, A Snyder, EC Kaye, JN Baker Bone marrow transplantation 55 (6), 1103-1113, 2020 | 12 | 2020 |
| Latent human herpesvirus 6 is reactivated in CAR T cells CA Lareau, Y Yin, K Maurer, KD Sandor, B Daniel, G Yagnik, J Peña, ... Nature 623 (7987), 608-615, 2023 | 10 | 2023 |
| Outcomes of pediatric patients who relapse after first HCT for acute leukemia or MDS A Sharma, Y Li, S Huang, AC Talleur, A Suliman, A Qudeimat, ... Bone Marrow Transplantation 56 (8), 1866-1875, 2021 | 10 | 2021 |
| Extracorporeal membrane oxygenation candidacy in pediatric patients treated with hematopoietic stem cell transplant and chimeric antigen receptor T-cell therapy: An … S Ghafoor, K Fan, M Di Nardo, AC Talleur, A Saini, RM Potera, ... Frontiers in Oncology 11, 798236, 2021 | 8 | 2021 |
| Autologous hematopoietic cell transplantation for the treatment of relapsed/refractory pediatric, adolescent, and young adult Hodgkin lymphoma: a single institutional experience AC Talleur, JE Flerlage, DR Shook, AM Chilsen, MM Hudson, C Cheng, ... Bone Marrow Transplantation 55 (7), 1357-1366, 2020 | 8 | 2020 |
Brandon M. Triplett, M.D.Associate Member, Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude ChildrenVerified email at stjude.org
